Skip to Content
Merck

Skip To

C6035

Caffeine solution

analytical standard, 1.0 mg/mL in methanol

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
1 mL
Please contact Customer Service for Availability
CZK 2,170.00

About This Item

CAS Number:
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
12352210
MDL number:

CZK 2,170.00


Please contact Customer Service for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

analytical standard

Quality Segment

concentration

1.0 mg/mL in methanol

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

pharmaceutical (small molecule)

format

single component solution

storage temp.

2-8°C

SMILES string

CN1C(=O)N(C)c2ncn(C)c2C1=O

InChI

1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3

InChI key

RYYVLZVUVIJVGH-UHFFFAOYSA-N

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Caffeine solution may be used as a surrogate standard for the determination of selected antibiotics like ofloxacin, norfloxacin, roxithromycin, erythromycin-H2O, sulfadiazine, sulfadimidine, sulfamethoxazole, amoxicillin and chloramphenicol in water samples using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry(HPLC-MS-MS).

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
PHR1009PHR1095C1778
grade

analytical standard

grade

certified reference material, pharmaceutical secondary standard

grade

certified reference material, pharmaceutical secondary standard

grade

-

format

single component solution

format

neat

format

neat

format

-

Quality Level

200

Quality Level

300

Quality Level

300

Quality Level

200

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

-

concentration

1.0 mg/mL in methanol

concentration

-

concentration

-

concentration

-

storage temp.

2-8°C

storage temp.

2-30°C

storage temp.

2-30°C

storage temp.

-


Still not finding the right product?

Explore all of our products under Caffeine solution


signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

51.8 °F - closed cup

flash_point_c

11 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

67-56-1

CAS No.


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Xu W H, et al.
Environmental Pollution (Barking, Essex : 1987), 145(3), 145(3)-145(3) (2007)
J N Cornu
Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 65(1), 21-35 (2013-03-30)
Overactive bladder (OAB) is defined by its hallmark symptom, urgency. It can be associated with urge urinary incontinence (UUI), and dramatically impact the patients' quality of life. Etiologies of OAB are numerous, and under this common wording, virtually all the
Lisa N Sharwood et al.
BMJ (Clinical research ed.), 346, f1140-f1140 (2013-03-21)
To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers. Case-control study. New South Wales (NSW) and Western Australia (WA), Australia. 530 long distance drivers



Global Trade Item Number

SKUGTIN
C6035-1ML04061833503065

Questions

Reviews

No rating value

Active Filters